SEC CIK 2024911
ENGELHARDT EVA ANETTE
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| BIO BIO.Bview stock → | 1,828 | 2026-09-06 |
| BIOview stock → | 0 | 2024-06-10 |
Position History — BIO BIO.B
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — BIO BIO.B
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-09-06 | Option exercise (derivative) | 1,152 | $0.00 | 2,304 |
| 2026-09-06 | Tax withholding | 485 | $386.11 | 1,828 |
| 2026-09-06 | Option exercise | 1,152 | $0.00 | 2,313 |
| 2026-09-05 | Option exercise (derivative) | 1,027 | $0.00 | 3,083 |
| 2026-09-05 | Tax withholding | 369 | $386.11 | 1,161 |
| 2026-09-05 | Option exercise | 1,027 | $0.00 | 1,530 |
| 2026-09-04 | Grant / award (derivative) | 4,313 | $0.00 | 4,313 |
| 2026-07-25 | Option exercise (derivative) | 246 | $0.00 | 492 |
| 2026-07-25 | Tax withholding | 89 | $314.46 | 503 |
| 2026-07-25 | Option exercise | 246 | $0.00 | 592 |
| 2026-05-11 | Open-market sale | 550 | $246.54 | 346 |
| 2025-09-06 | Option exercise (derivative) | 1,152 | $0.00 | 3,456 |
| 2025-09-06 | Tax withholding | 413 | $295.43 | 896 |
| 2025-09-06 | Option exercise | 1,152 | $0.00 | 1,309 |
| 2025-09-05 | Grant / award (derivative) | 4,110 | $0.00 | 4,110 |
| 2025-07-25 | Option exercise (derivative) | 245 | $0.00 | 738 |
| 2025-07-25 | Tax withholding | 88 | $264.19 | 157 |
| 2025-07-25 | Option exercise | 245 | $0.00 | 245 |
| 2025-03-03 | Grant / award (derivative) | 2,918 | $0.00 | 2,918 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.